NeuroMetrix Reports Q4 and Full Year 2017 Financial Results
WALTHAM, Mass., Jan. 25, 2018 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO), today reported financial and business highlights for the quarter ended December 31, 2017. The Company develops and markets novel therapies, based on neurostimulation and …